Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

NCT00200512 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: apomorphine HCl injection

Sponsor

Mylan Bertek Pharmaceuticals